Plasma N-terminal pro-B-type natriuretic peptide concentration in healthy retired racing Greyhounds

© 2015 American Society for Veterinary Clinical Pathology.

Détails bibliographiques
Publié dans:Veterinary clinical pathology. - 1975. - 44(2015), 3 vom: 01. Sept., Seite 405-9
Auteur principal: Couto, Kristen M (Auteur)
Autres auteurs: Iazbik, M Cristina, Marín, Liliana M, Zaldivar-López, Sara, Beal, Melissa J, Gómez Ochoa, P, Couto, C Guillermo
Format: Article en ligne
Langue:English
Publié: 2015
Accès à la collection:Veterinary clinical pathology
Sujets:Comparative Study Journal Article Athlete's heart cardiac biomarkers cardiac disease congestive heart failure sighthound Biomarkers Peptide Fragments Troponin I plus... pro-brain natriuretic peptide (1-76) Natriuretic Peptide, Brain 114471-18-0
Description
Résumé:© 2015 American Society for Veterinary Clinical Pathology.
BACKGROUND: N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a cardiac biomarker whose plasma concentration is high in some dogs with cardiopulmonary disease. NT-proBNP is a diagnostic tool that can be used to help determine if a patient has congestive heart failure. Greyhounds have functional heart murmurs, relative cardiomegaly, and high serum cTnI concentration
OBJECTIVES: The purpose of the study was to evaluate the plasma concentration of NT-proBNP in healthy Greyhounds and compare it to non-Greyhound dogs
METHODS: We prospectively evaluated healthy client-owned dogs including retired racing Greyhounds and non-Greyhounds. Plasma was obtained and transferred into tubes containing a protease inhibitor and submitted for a specific NT-proBNP ELISA assay
RESULTS: The plasma NT-proBNP concentration in Greyhounds was significantly higher than in non-Greyhound control dogs (946 vs 632 pmol/L; P < .005); 46% of Greyhounds had NT-proBNP > 1000 pmol/L
CONCLUSIONS: Plasma NT-proBNP concentration in Greyhounds is high and should be interpreted with caution
Description:Date Completed 13.12.2016
Date Revised 30.12.2016
published: Print-Electronic
Citation Status MEDLINE
ISSN:1939-165X
DOI:10.1111/vcp.12266